Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Jemincare clinical trials
The registry lists 36 studies whose lead sponsor is Jemincare. 29 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 30, 2026.
Keep track of what changes. Save the Jemincare studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- China
- 24
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Jemincare.
- Jemincare36 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 36 of 36.
- A Study of JMKX003142 Tablet to Treat Renal EdemaNot yet recruitingNCT07841093Phase 3
- Phase I Study of JY1001 InjectionNot yet recruitingNCT07848945Phase 1
- Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.RecruitingNCT07402213Phase 3
- Drug-Drug Interactions of JMKX003142 in Healthy ParticipantsNot yet recruitingNCT07565441Phase 1
- Trial of JYB1904 Injection in Adolescent ParticipantsNot yet recruitingNCT07513857Phase 1
- A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy AdultsNot yet recruitingNCT07470177Phase 1
- Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy VolunteersNot yet recruitingNCT07463053Phase 1
- Trial of JYB1904 Injection in Patients With Perennial Allergic RhinitisNot yet recruitingNCT07459452Phase 2
- A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid TumorsRecruitingNCT07208136Phase 1
- Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLCNot yet recruitingNCT07242274Phase 3
- Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy SubjectsNot yet recruitingNCT07181265Phase 1
- Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)RecruitingNCT06800651Phase 2
- A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C MutationRecruitingNCT06946927Phase 1
- A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural EffusionRecruitingNCT06740019Phase 1
- Study of JMKX003948 Ophthalmic Suspension in Healthy ParticipantsNot yet recruitingNCT06832657Phase 1
- Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with HyperphosphatemiaRecruitingNCT06664125Phase 2
- Trial of JYB1904 in Chronic Spontaneous Urticaria.RecruitingNCT06509334Phase 2
- Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy SubjectsNot yet recruitingNCT06658964Phase 1
- Trial of JMKX003801 in Healthy ParticipantsRecruitingNCT06549309Phase 1
- A Study of JMKX003948 Tablets in Patients With Renal Cell CarcinomaRecruitingNCT06321250Phase 1
- To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy SubjectsNot yet recruitingNCT06473948Phase 1
- Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic PainRecruitingNCT06221241Phase 2
- Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy SubjectsNot yet recruitingNCT06348290Phase 1
- Study of JMKX003142 Injection in Chinese Healthy SubjectsNot yet recruitingNCT06344533Phase 1
- Phase 1 Clinical Study of JMKX003142 TabletsRecruitingNCT06079541Phase 1
- JMKX000189 for Moderate to Severe Active Systemic Lupus ErythematosusRecruitingNCT05967520Phase 2
- A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural EffusionRecruitingNCT05923515Phase 1
- JYB1907 in Subjects With Advanced Solid TumorsNot yet recruitingNCT05821595Phase 1
- Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy SubjectsRecruitingNCT05907382Phase 1
- A Dose-finding Study of JMKX003142 in Treatment of Renal EdemaCompletedNCT06670534Phase 2
- A Dose-finding Study of JMKX003142 in Treatment of Cardiac EdemaCompletedNCT06949020Phase 2
- Trial of JYB1904 in Patients With Allergic AsthmaCompletedNCT06438757Phase 2
- Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in ChinaCompletedNCT06880848Phase 4
- A DDI Study of JMKX000623 and Metformin HydrochlorideCompletedNCT06066060Phase 1
- Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese SubjectsCompletedNCT05449535Phase 1
- Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to GlomerulonephritisStatus unknownNCT04349683Phase 4